Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
Cytoplasmic Antigen in Hepatocytes of Chimpanzees Infected With Non–A, Non–B Hepatitis Virus or Hepatitis Delta Virus: Relationship to Interferon
1989
Hepatitis C Virus Infection
2001 Standout
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay
1991 StandoutNobel
Treatment triumphs
2014 StandoutNatureNobel
ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDS
1989 StandoutNobel
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Detection of hepatitis C viral sequences in non-A, non-B hepatitis
1990
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
1989 StandoutNobel
Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections
2008
Lack of Protective Immunity Against Reinfection with Hepatitis C Virus
1992 Science
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Parenterally transmitted non-A, non-B hepatitis: Virus-specific antibody response patterns in hepatitis C virus-infected chimpanzees
1990
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
1989 StandoutNobel
Characteristics of patients with dual infection by hepatitis B and C viruses
1998
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1989 StandoutNobel
A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan
1989 StandoutNobel
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
T-lymphocyte response to hepatitis C virus in different clinical courses of infection
1993 StandoutNobel
Hepatitis C virus: Historical perspective and current concept
1994
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
Discovery of non-A, non-B hepatitis and identification of its etiology
1999
Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers
1990 StandoutNobel
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
The role of senescent cells in ageing
2014 StandoutNature
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma
1990 StandoutNobel
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein
2004 StandoutNobel
Hepatitis C Virus Nonstructural Proteins Are Localized in a Modified Endoplasmic Reticulum of Cells Expressing Viral Subgenomic Replicons
2002
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Hepatitis C antibody and chronic liver disease in haemophilia
1990 StandoutNobel
Non-A, Non-B Hepatitis in Chimpanzees and Marmosets
1981
Transfusion-Transmitted Viruses Study: Experimental Evidence for Two Non-A, Non-B Hepatitis Agents
1980
Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C.
1993 StandoutNobel
Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals
2017
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
1999 StandoutScience
Binding of Hepatitis C Virus to CD81
1998 StandoutScienceNobel
The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay.
1995 StandoutNobel
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
1989 StandoutScienceNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
The agents of non-A, non-B viral hepatitis
1985
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.
1995 StandoutNobel
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
1983
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
1996 StandoutNobel
Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus.
1985
The Natural Course of Hepatitis B Surface Antigen—Positive Chronic Active Hepatitis in Taiwan
1982
Transmission of Hepatitis C by Intrahepatic Inoculation with Transcribed RNA
1997 StandoutScienceNobel
Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end.
1991 StandoutNobel
The pathology of viral hepatitis in chimpanzees
1980
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
The pathology of viral hepatitis in chimpanzees.
1980
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.
1990 StandoutNobel
Posttransfusion Non-A, Non-B Hepatitis: Physicochemical Properties of Two Distinct Agents
1983
Early events in hepatitis C virus infection of chimpanzees.
1990 StandoutNobel
Genetic organization and diversity of the hepatitis C virus.
1991 Standout
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 StandoutScienceNobel
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Works of Bert L. Murphy being referenced
Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
1981
Occurrence of a Carrier State for Herpesvirus tamarinus in Marmosets
1971
Non‐A, non‐b hepatitis in chimpanzees: Interference with acute hepatitis A virus and chronic hepatitis B virus infections
1983
Occurrence of a Carrier State for Herpesvirus tamarinus in Marmosets
1971
Experimental infection of chimpanzees with antihemophilic (factor viii) materials: Recovery of virus‐like particles associated with non‐A, non‐B hepatitis
1979